Αναζήτηση

σε πρόσθεσε στο άλλο

2025-11-26 08:57:13 -

Bio simulation Market to Surge to USD 16.69 Billion by 2032 Riding a 16.23% CAGR on Rising Biologics R&D, AI-Enabled Modelling and Demand for Cost-Efficient Drug Development

Biosimulation Market remarkable growth is being driven by a confluence of factors: rapid expansion in biologics and biosimilar development, the escalating burden of chronic diseases, rising demand for precision medicine, and regulatory momentum favoring in-silico simulation to streamline drug development, reduce costs, and accelerate time-to-market. Quick Insights...

0 Σχόλια 0 Μοιράστηκε 9 Views 0 Προεπισκόπηση